Radiotherapy plays a critical role in treating esophageal cancer, but individual responses vary significantly, impacting patient outcomes. This study integrates machine learning-driven multimodal radiomics and transcriptomics to develop predictive models for radiotherapy sensitivity and prognosis in esophageal cancer. We applied the SEResNet101 deep learning model to imaging and transcriptomic data from the UCSC Xena and TCGA databases, identifying prognosis-associated genes such as STUB1, PEX12, and HEXIM2. Using Lasso regression and Cox analysis, we constructed a prognostic risk model that accurately stratifies patients based on survival probability. Notably, STUB1, an E3 ubiquitin ligase, enhances radiotherapy sensitivity by promoting the ubiquitination and degradation of SRC, a key oncogenic protein. In vitro and in vivo experiments confirmed that STUB1 overexpression or SRC silencing significantly improves radiotherapy response in esophageal cancer models. These findings highlight the predictive power of multimodal data integration for individualized radiotherapy planning and underscore STUB1 as a promising therapeutic target for enhancing radiotherapy efficacy in esophageal cancer.

Minimally invasive surgery involves entering the body through small incisions or natural orifices, using a medical endoscope for observation and clinical procedures. However, traditional endoscopic images often suffer from low texture and uneven illumination, which can negatively impact surgical and diagnostic outcomes. To address these challenges, many researchers have applied deep learning methods to enhance the processing of endoscopic images. This paper proposes a monocular medical endoscopic image depth estimation method based on a window-adaptive asymmetric dual-branch Siamese network. In this network, one branch focuses on processing global image information, while the other branch concentrates on local details. An improved lightweight Squeeze-and-Excitation (SE) module is added to the final layer of each branch, dynamically adjusting the inter-channel weights through self-attention. The outputs from both branches are then integrated using a lightweight cross-attention feature fusion module, enabling cross-branch feature interaction and enhancing the overall feature representation capability of the network. Extensive ablation and comparative experiments were conducted on medical datasets (EAD2019, Hamlyn, M2caiSeg, UCL) and a non-medical dataset (NYUDepthV2), with both qualitative and quantitative results-measured in terms of RMSE, AbsRel, FLOPs and running time-demonstrating the superiority of the proposed model. Additionally, comparisons with CT images show good organ boundary matching capability, highlighting the potential of our method for clinical applications. The key code of this paper is available at: https://github.com/superchongcnn/AttenAdapt_DE .

To explore whether a CT-based AI framework, leveraging multi-scale features, can offer a non-invasive approach to accurately predict pathological grade and Ki67 index in clear cell renal cell carcinoma (ccRCC). In this multicenter retrospective study, a total of 1073 pathologically confirmed ccRCC patients from seven cohorts were split into internal cohorts (training and validation sets) and an external test set. The AI framework comprised an image processor, a 3D-kidney and tumor segmentation model by 3D-UNet, a multi-scale features extractor built upon unsupervised learning, and a multi-task classifier utilizing XGBoost. A quantitative model interpretation technique, known as SHapley Additive exPlanations (SHAP), was employed to explore the contribution of multi-scale features. The 3D-UNet model showed excellent performance in segmenting both the kidney and tumor regions, with Dice coefficients exceeding 0.92. The proposed multi-scale features model exhibited strong predictive capability for pathological grading and Ki67 index, with AUROC values of 0.84 and 0.87, respectively, in the internal validation set, and 0.82 and 0.82, respectively, in the external test set. The SHAP results demonstrated that features from radiomics, the 3D Auto-Encoder, and dimensionality reduction all made significant contributions to both prediction tasks. The proposed AI framework, leveraging multi-scale features, accurately predicts the pathological grade and Ki67 index of ccRCC. The CT-based AI framework leveraging multi-scale features offers a promising avenue for accurately predicting the pathological grade and Ki67 index of ccRCC preoperatively, indicating a direction for non-invasive assessment. Non-invasively determining pathological grade and Ki67 index in ccRCC could guide treatment decisions. The AI framework integrates segmentation, classification, and model interpretation, enabling fully automated analysis. The AI framework enables non-invasive preoperative detection of high-risk tumors, assisting clinical decision-making.

Urodynamic studies (UDS) are essential for evaluating lower urinary tract function but are limited by patient discomfort, lack of standardization and diagnostic variability. Advances in technology aim to address these challenges and improve diagnostic accuracy and patient comfort. AUM offers physiological assessment by allowing natural bladder filling and monitoring during daily activities. Compared to conventional UDS, AUM demonstrates higher sensitivity for detecting detrusor overactivity and underlying pathophysiology. However, it faces challenges like motion artifacts, catheter-related discomfort, and difficulty measuring continuous bladder volume. Emerging devices such as Urodynamics Monitor and UroSound offer more patient-friendly alternatives. These tools have the potential to improve diagnostic accuracy for bladder pressure and voiding metrics but remain limited and still require further validation and testing. Ultrasound-based modalities, including dynamic ultrasonography and shear wave elastography, provide real-time, noninvasive assessment of bladder structure and function. These modalities are promising but will require further development of standardized protocols. AI and machine learning models enhance diagnostic accuracy and reduce variability in UDS interpretation. Applications include detecting detrusor overactivity and distinguishing bladder outlet obstruction from detrusor underactivity. However, further validation is required for clinical adoption. Advances in AUM, wearable technologies, ultrasonography, and AI demonstrate potential for transforming UDS into a more accurate, patient-centered tool. Despite significant progress, challenges like technical complexity, standardization, and cost-effectiveness must be addressed to integrate these innovations into routine practice. Nonetheless, these technologies provide the possibility of a future of improved diagnosis and treatment of lower urinary tract dysfunction.

Acute kidney injury (AKI) post-renal transplantation often has a poor prognosis. This study aimed to identify patients with elevated risks of AKI after kidney transplantation. A retrospective analysis was conducted on 422 patients who underwent kidney transplants from January 2020 to April 2023. Participants from 2020 to 2022 were randomized to training group (n=261) and validation group 1 (n=113), and those in 2023, as validation group 2 (n=48). Risk factors were determined by employing logistic regression analysis alongside the least absolute shrinkage and selection operator, making use of ultrasound hemodynamic, clinical, and laboratory information. Models for prediction were developed using logistic regression analysis and six machine-learning techniques. The evaluation of the logistic regression model encompassed its discrimination, calibration, and applicability in clinical settings, and a nomogram was created to illustrate the model. SHapley Additive exPlanations were used to explain and visualize the best of the six machine learning models. The least absolute shrinkage and selection operator combined with logistic regression identified and incorporated five risk factors into the predictive model. The logistic regression model (AUC=0.927 in the validation set 1; AUC=0.968 in the validation set 2) and the random forest model (AUC=0.946 in the validation set 1;AUC=0.996 in the validation set 2) showed good performance post-validation, with no significant difference in their predictive accuracy. These findings can assist clinicians in the early identification of patients at high risk for AKI, allowing for timely interventions and potentially enhancing the prognosis following kidney transplantation.

To evaluate the possibility of performing renal vessel reconstruction on non-enhanced CT images using deep learning models. 177 patients' CT scans in the non-enhanced phase, arterial phase and venous phase were chosen. These data were randomly divided into the training set (n = 120), validation set (n = 20) and test set (n = 37). In training set and validation set, a radiologist marked out the right renal arteries and veins on non-enhanced CT phase images using contrast phases as references. Trained deep learning models were tested and evaluated on the test set. A radiologist performed renal vessel reconstruction on the test set without the contrast phase reference, and the results were used for comparison. Reconstruction using the arterial phase and venous phase was used as the gold standard. Without the contrast phase reference, both radiologist and model could accurately identify artery and vein main trunk. The accuracy was 91.9% vs. 97.3% (model vs. radiologist) in artery and 91.9% vs. 100% in vein, the difference was insignificant. The model had difficulty identify accessory arteries, the accuracy was significantly lower than radiologist (44.4% vs. 77.8%, p = 0.044). The model also had lower accuracy in accessory veins, but the difference was insignificant (64.3% vs. 85.7%, p = 0.094). Deep learning models could accurately recognize the right renal artery and vein main trunk, and accuracy was comparable to that of radiologists. Although the current model still had difficulty recognizing small accessory vessels, further training and model optimization would solve these problems.

Artificial intelligence applications in oncology imaging often struggle with diagnosing rare tumors. We identify significant gaps in detecting uncommon thyroid cancer types with ultrasound, where scarce data leads to frequent misdiagnosis. Traditional augmentation strategies do not capture the unique disease variations, hindering model training and performance. To overcome this, we propose a text-driven generative method that fuses clinical insights with image generation, producing synthetic samples that realistically reflect rare subtypes. In rigorous evaluations, our approach achieves substantial gains in diagnostic metrics, surpasses existing methods in authenticity and diversity measures, and generalizes effectively to other private and public datasets with various rare cancers. In this work, we demonstrate that text-guided image augmentation substantially enhances model accuracy and robustness for rare tumor detection, offering a promising avenue for more reliable and widespread clinical adoption.

Diagnosis of peritoneal invasion, lymph node metastasis, and hepatic metastasis is crucial in the decision-making process of ovarian tumor treatment. This study aimed to test the feasibility of low-dose abdominopelvic CT with an artificial intelligence iterative reconstruction (AIIR) for diagnosing peritoneal invasion, lymph node metastasis, and hepatic metastasis in pre-operative imaging of ovarian tumor. This study prospectively enrolled 88 patients with pathology-confirmed ovarian tumors, where routine-dose CT at portal venous phase (120 kVp/ref. 200 mAs) with hybrid iterative reconstruction (HIR) was followed by a low-dose scan (120 kVp/ref. 40 mAs) with AIIR. The performance of diagnosing peritoneal invasion and lymph node metastasis was assessed using receiver operating characteristic (ROC) analysis with pathological results serving as the reference. The hepatic parenchymal metastases were diagnosed and signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) were measured. The perihepatic structures were also scored on the clarity of porta hepatis, gallbladder fossa and intersegmental fissure. The effective dose of low-dose CT was 79.8% lower than that of routine-dose scan (2.64 ± 0.46 vs. 13.04 ± 2.25 mSv, p < 0.001). The low-dose AIIR showed similar area under the ROC curve (AUC) with routine-dose HIR for diagnosing both peritoneal invasion (0.961 vs. 0.960, p = 0.734) and lymph node metastasis (0.711 vs. 0.715, p = 0.355). The 10 hepatic parenchymal metastases were all accurately diagnosed on the two image sets. The low-dose AIIR exhibited higher SNR and CNR for hepatic parenchymal metastases and superior clarity for perihepatic structures. In low-dose pre-operative CT of ovarian tumor, AIIR delivers similar diagnostic accuracy for peritoneal invasion, lymph node metastasis, and hepatic metastasis, as compared to routine-dose abdominopelvic CT. It is feasible and diagnostically safe to apply up to 80% dose reduction in CT imaging of ovarian tumor by using AIIR.

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=111 SRC="FIGDIR/small/25326981v1_ufig1.gif" ALT="Figure 1"> View larger version (31K): [email protected]@14e7b87org.highwire.dtl.DTLVardef@19005c4org.highwire.dtl.DTLVardef@6ac42f_HPS_FORMAT_FIGEXP M_FIG O_FLOATNOGraphical AbstractC_FLOATNO C_FIG HighlightsO_LIA retrospective cohort of liver biopsies collected from over 20 healthcare centres has been assembled. C_LIO_LIThe cohort is characterized on the basis of collagen staining used for liver fibrosis assessment. C_LIO_LIA computational pipeline for the quantification of collagen from liver histology slides has been developed and applied to the described cohorts. C_LIO_LIUncertainty estimation is evaluated as a method to build trust in deep-learning based collagen predictions. C_LI The introduction of digital pathology has revolutionised the way in which histology-based measurements can support large, multi-centre studies. How-ever, pooling data from various centres often reveals significant differences in specimen quality, particularly regarding histological staining protocols. These variations present challenges in reliably quantifying features from stained tissue sections using image analysis. In this study, we investigate the statistical variation of measuring fibrosis across a liver cohort composed of four individual studies from 20 clinical sites across Europe and North America. In a first step, we apply colour consistency measurements to analyse staining variability across this diverse cohort. Subsequently, a learnt segmentation model is used to quantify the collagen proportionate area (CPA) and employed uncertainty mapping to evaluate the quality of the segmentations. Our analysis highlights a lack of standardisation in PicroSirius Red (PSR) staining practices, revealing significant variability in staining protocols across institutions. The deconvolution of the staining of the digitised slides identified the different numbers and types of counterstains used, leading to potentially incomparable results. Our analysis highlights the need for standardised staining protocols to ensure reliable collagen quantification in liver biopsies. The tools and methodologies presented here can be applied to perform slide colour quality control in digital pathology studies, thus enhancing the comparability and reproducibility of fibrosis assessment in the liver and other tissues.

Deep learning reconstruction (DLR) provides an elegant solution for MR acceleration while preserving image quality. This advancement is crucial for body imaging, which is frequently marred by the increased likelihood of motion-related artifacts. Multiple vendor-specific models focusing on T2, T1, and diffusion-weighted imaging have been developed for the abdomen, pelvis, and chest, with the liver and prostate being the most well-studied organ systems. Variational networks with supervised DL models, including data consistency layers and regularizers, are the most common DLR methods. The common theme for all single-center studies on this subject has been noninferior or superior image quality metrics and lesion conspicuity to conventional sequences despite significant acquisition time reduction. DLR also provides a potential for denoising, artifact reduction, increased resolution, and increased signal-noise ratio (SNR) and contrast-to-noise ratio (CNR) that can be balanced with acceleration benefits depending on the imaged organ system. Some specific challenges faced by DLR include slightly reduced lesion detection, cardiac motion-related signal loss, regional SNR variations, and variabilities in ADC measurements as reported in different organ systems. Continued investigations with large-scale multicenter prospective clinical validation of DLR to document generalizability and demonstrate noninferior diagnostic accuracy with histopathologic correlation are the need of the hour. The creation of vendor-neutral solutions, open data sharing, and diversifying training data sets are also critical to strengthening model robustness.